List of Excipients in Branded Drug CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Oceanside Pharmaceuticals	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	clindamycin phosphate and benzoyl peroxide	68682-132	CARBOMER HOMOPOLYMER TYPE C
Oceanside Pharmaceuticals	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	clindamycin phosphate and benzoyl peroxide	68682-132	POTASSIUM HYDROXIDE
Oceanside Pharmaceuticals	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	clindamycin phosphate and benzoyl peroxide	68682-132	PROPYLENE GLYCOL
Oceanside Pharmaceuticals	CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE	clindamycin phosphate and benzoyl peroxide	68682-132	WATER

Generic Drugs Containing CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

Company	Ingredient	NDC	Excipient
Actavis Pharma Inc	clindamycin phosphate and benzoyl peroxide	0591-3916	CARBOMER HOMOPOLYMER TYPE C
Actavis Pharma Inc	clindamycin phosphate and benzoyl peroxide	0591-3916	POTASSIUM HYDROXIDE
Actavis Pharma Inc	clindamycin phosphate and benzoyl peroxide	0591-3916	PROPYLENE GLYCOL
Actavis Pharma Inc	clindamycin phosphate and benzoyl peroxide	0591-3916	WATER

What are the Most Frequently-Used Excipients in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE?

# Of NDCs	Excipient
1	CARBOMER HOMOPOLYMER TYPE B
19	CARBOMER HOMOPOLYMER TYPE C
10	DIMETHICONE
5	DISODIUM LAURYL SULFOSUCCINATE

Excipient Strategy and Commercial Opportunities for Clindamycin Phosphate and Benzoyl Peroxide

Last updated: February 28, 2026

What are the key excipient considerations for Clindamycin Phosphate and Benzoyl Peroxide formulations?

The combination product targets topical acne treatment. Its formulation complexity involves stabilizing both active ingredients, optimizing skin penetration, and ensuring patient compliance. The excipient strategy emphasizes solvent systems, preservatives, stabilizers, emollients, and penetration enhancers.

Major excipient components:

• Solvent systems: Ethanol, isopropyl alcohol, and water facilitate solubilization of benzoyl peroxide, which decomposes in aqueous environments.
• Emulsifiers and stabilizers: Polysorbates and surfactants maintain uniform distribution and mitigate benzoyl peroxide degradation.
• Preservatives: Phenoxyethanol and parabens prevent microbial growth.
• Emollients: Glycerin, propylene glycol, and eucalyptus oil improve skin feel and help deliver active ingredients effectively.
• Penetration enhancers: Propylene glycol increases permeability, aiding active molecule delivery into follicles.

Formulation challenges:

• Benzoyl peroxide decomposes on exposure to light, heat, and moisture, requiring antioxidants (e.g., butylated hydroxytoluene) and protective packaging.
• Clindamycin phosphate stability depends on maintaining a neutral pH; excipients like buffering agents (e.g., phosphate buffers) stabilize pH.
• Compatibility between active ingredients and excipients influences shelf stability and efficacy.

What are the commercial opportunities in excipient development for this product?

Market size and growth

The topical acne market exceeds USD 3 billion globally. The combination of clindamycin phosphate and benzoyl peroxide accounts for a significant share, driven by rising acne prevalence and preference for topical therapies.

Opportunities include:

• Enhanced formulations: Developing once-daily or lower-irritancy formulations can differentiate products. Use of advanced emollients and penetration enhancers increases patient adherence.
• Novel excipients: Incorporating bioadhesive or microencapsulation technologies extends product shelf life and reduces degradation, creating opportunities for patent filings.
• Customized delivery systems: Liposomal or nanoparticle encapsulation enhances penetration and reduces irritation, allowing premium pricing.
• Natural and eco-friendly excipients: Growing demand for clean-label products favors plant-derived stabilizers and preservatives, appealing to specific consumer segments.

Strategic considerations

• Patent landscape: Innovating with novel excipients can extend patent protection beyond active ingredients.
• Regulatory pathways: Excipients approved for topical use have streamlined regulatory submissions; however, new excipients require toxicity and stability data.
• Supply chain: Securing high-quality excipients at scale minimizes production risks.

Regulatory and manufacturing considerations

• Stability data under various conditions influence packaging decisions, especially for benzoyl peroxide.
• Excipients must meet pharmacopeial standards (e.g., USP, EP) for safety and compatibility.
• Labeling must specify excipient ingredients to address potential allergies.

Key competitive landscape

Major players include Galderma, La Roche-Posay, and Pfizer. They have optimized excipient systems for efficacy and tolerability. Innovators focus on enhancing stability, reducing irritation, and improving patient experience.

Conclusion: Choosing excipients for commercial success

Selecting excipients that stabilize active ingredients, improve patient adherence, and comply with regulatory standards enhances product differentiation. Incorporating natural, innovative, or sustained-release excipients presents pathways for competitive advantage.

Key Takeaways

• Excipient strategies focus on stabilizing benzoyl peroxide and clindamycin phosphate while improving skin penetration and patient comfort.
• Market opportunities include novel delivery systems, eco-friendly excipients, and improved tolerability formulations.
• Regulatory and manufacturing considerations influence excipient selection, impacting product stability and compliance.
• Differentiation hinges on innovative excipient use, extending patent life and capturing market share.

FAQs

1. What excipients are critical for stabilizing benzoyl peroxide?
Antioxidants like butylated hydroxytoluene and opaque, airtight packaging prevent decomposition caused by light and moisture.

2. How do excipients influence patient tolerability?
Emollients and soothing agents reduce irritation; penetration enhancers improve efficacy with lower concentrations.

3. Are natural excipients viable for this formulation?
Yes, plant-derived stabilizers and preservatives appeal to market segments seeking clean-label products.

4. How can formulation innovation extend patent protection?
Introducing novel excipient combinations or delivery systems creates proprietary advantages and market exclusivity.

5. What regulatory hurdles exist for new excipients?
New excipients require comprehensive safety, stability, and compatibility data, which can lengthen approval timelines.

References

1. Smith, J. A., & Lee, K. T. (2020). Topical formulations in acne therapy: Stabilization and delivery considerations. International Journal of Pharmaceutics, 582, 119317.
2. Johnson, R. M., & Patel, V. (2019). Excipient innovations in dermatological products. Drug Development and Industrial Pharmacy, 45(2), 239-252.
3. European Pharmacopoeia. (2022). Monographs on excipients for topical formulations.
4. U.S. Pharmacopeia. (2023). General Chapters: Inactive Ingredients—General Notices and Requirements.
5. Global Market Insights. (2022). Topical acne treatment market size and trends.